Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies

Bladder cancer (BCa) is an endocrine-related tumour and the activation of androgen signalling pathways may promote bladder tumorigenesis. We summarized the available preclinical and clinical evidence on the implications of the manipulation of androgen signalling pathways on the outcomes of BCa thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Creta, Massimiliano, Celentano, Giuseppe, Napolitano, Luigi, La Rocca, Roberto, Capece, Marco, Califano, Gianluigi, Collà Ruvolo, Claudia, Mangiapia, Francesco, Morra, Simone, Turco, Carmine, Spirito, Lorenzo, Fusco, Ferdinando, Imbimbo, Ciro, Mirone, Vincenzo, Longo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923424/
https://www.ncbi.nlm.nih.gov/pubmed/33672461
http://dx.doi.org/10.3390/diagnostics11020351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923424/
https://www.ncbi.nlm.nih.gov/pubmed/33672461
http://dx.doi.org/10.3390/diagnostics11020351

Ejemplares similares